Based on the above, this review summarizes the ncRNAs in the PAM signaling pathway of PCa and tries to find AKT inhibitor breakthroughs from the function and clinical use of these ncRNAs for better treatment of PCa. Here, AKT1 is linked to posterior cortical atrophy.